{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:39Z","timestamp":1790014839035,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T00:00:00Z","timestamp":1090972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00417-004-0961-4","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T13:43:25Z","timestamp":1090935805000},"page":"9-12","source":"Crossref","is-referenced-by-count":25,"title":["Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration"],"prefix":"10.1007","volume":"243","author":[{"given":"Albert J.","family":"Augustin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Mieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Schneebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,28]]},"reference":[{"key":"961_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00006982-200302000-00003","volume":"23","author":"Anecortave","year":"2003","unstructured":"Anecortave Acetate Clinical Study Group (2003) Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina 23:14\u201323","journal-title":"Retina"},{"key":"961_CR2","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.ophtha.2003.08.020","volume":"110","author":"Anecortave","year":"2003","unstructured":"Anecortave Acetate Clinical Study Group (2003) Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: the twelve-month clinical outcomes. Ophthalmology 110:2372\u20132383","journal-title":"Ophthalmology"},{"key":"961_CR3","first-page":"1954","volume":"38","author":"BenEzra","year":"1997","unstructured":"BenEzra D, Griffin BW, Maftzir G, Sharif NA, Clark AF (1997) Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 38:1954\u20131962","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"961_CR4","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1517\/13543784.6.12.1867","volume":"6","author":"Clark","year":"1997","unstructured":"Clark AF (1997) AL-3789: a novel ophthalmic angiostatic steroid. Expert Opin Investig Drugs 6:1867\u20131877","journal-title":"Expert Opin Investig Drugs"},{"key":"961_CR5","first-page":"2158","volume":"40","author":"Clark","year":"1999","unstructured":"Clark AF, Mellon J, Li X-Y, Ma D, Lieber H, Apte R, Alizadeh H, Hegde S, McLenaghan A, Mayhew E, D\u2019Orazio TJ, Niederkorn JY (1999) Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci 40:2158\u20132162","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"961_CR6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0161-6420(91)32135-3","volume":"98","author":"Cochereau-Massin","year":"1991","unstructured":"Cochereau-Massin I, Lehoang P, Lautier-Frau M, Zazoun L, Marcel P, Robinet M, Matheron S, Katlama C, Gharakhanian S, Rozenbaum W, Ingrand D, Gentilini M (1991) Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 98:1348\u20131355","journal-title":"Ophthalmology"},{"key":"961_CR7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/archopht.1989.01070020849025","volume":"107","author":"Heinemann","year":"1989","unstructured":"Heinemann M-H (1989) Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol 107:1767\u20131772","journal-title":"Arch Ophthalmol"},{"key":"961_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/jop.1999.15.413","volume":"15","author":"McNatt","year":"1999","unstructured":"McNatt LG, Weimer L, Yanni J, Clark AF (1999) Angiostatic activity of steroids in the chick embryo CAM and rabbit corneal pocket models of neovascularization. J Ocul Pharmacol 15:413\u2013423","journal-title":"J Ocul Pharmacol"},{"key":"961_CR9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","volume":"23","author":"Nelson","year":"2003","unstructured":"Nelson ML, Tennant MTS, Sivalingam A, Regillo CD, Belmont J, Martidis A (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686\u2013691","journal-title":"Retina"},{"key":"961_CR10","first-page":"283","volume":"42","author":"Penn","year":"2001","unstructured":"Penn JS, Rajaratnam VS, Collier RJ, Clark AF (2001) The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 42:283\u2013290","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-004-0961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-004-0961-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-004-0961-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:30:26Z","timestamp":1559071826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-004-0961-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,28]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["961"],"URL":"https:\/\/doi.org\/10.1007\/s00417-004-0961-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,28]]}}}